HOME >> BIOLOGY >> NEWS
Molecular staples shape a cancer killer

Howard Hughes Medical Institute (HHMI) researchers have successfully designed and improved a new type of cancer-killing compound by performing molecular surgery to stabilize the molecule so that it selectively triggers cell death.

The idea for developing the compound emerged from the HHMI laboratory of Stanley J. Korsmeyer, who leads one of the hottest research teams currently studying programmed cell death, or apoptosis, a genetic program that executes cells that are no longer needed. Using the biologically active portion of a protein that triggers apoptosis, Korsmeyer's team successfully inserted non-natural amino acids into the peptide sequence and then performed a chemical reaction that created a "staple" within the molecule, resulting in its stabilization. Korsmeyer and the paper's lead author, Loren D. Walensky, who are at the Dana-Farber Cancer Institute at Harvard Medical School, reported their studies in the September 3, 2004, issue of the journal Science.

The chemical approach they applied, called hydrocarbon stapling, was developed by their collaborator Gregory L. Verdine of Harvard University, and permitted the researchers to overcome the tendency of short peptides to lose their critical three-dimensional structure and their ability to kill cells -- when removed from the context of the complete protein. This has been one of the greatest obstacles associated with using short peptides as therapeutic agents, and has hindered their legitimacy as pharmaceutical lead compounds. By making the peptides more resistant to degradation and enabling their cellular uptake, the hydrocarbon staple overcomes classic shortcomings of peptide therapeutics.

As the molecular events that lead to execution and death have become clearer during the last decade, researchers speculated that it would not be long before biotechnology and pharmaceutical companies were racing to develop novel compounds that could be used to hasten or prevent the demise of c
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
2-Sep-2004


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular motor myosin VI moves hand over hand, researchers say
5. Molecular therapeutics advance fight against brain cancer
6. Molecular motor shuttles key protein in response to light
7. Molecular traffic cop directs cellular signals
8. Molecular marker predicts success of breast cancer treatment
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2019)... ... May 09, 2019 , ... Akadeum ... of products based on its microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy ... surface. Feedback from customers who participated in an early access program has been ...
(Date:5/8/2019)... ... May 08, 2019 , ... RG+A, Inc., a leading ... Mann has agreed to serve as Chief Executive Officer and pharmaceutical leader Dr. ... immediately. They will join Chairman and Founder Roger Green to create a three-person ...
(Date:5/8/2019)... ... May 08, 2019 , ... Great Point Partners (“GPP”) ... of unified eClinical solutions and services that are used to enhance the efficiency ... a leading e-clinical technology company that focuses on Electronic Data Capture (“EDC”), Data ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, Inc., a developer ... bench plant expansion to increase production of methylene malonate monomers and oligomers. , ... of Sirrus’ full-scale production facility, which is scheduled to break ground in 2019. ...
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny for ... approximately two months. After a series of diagnostics, an MRI was performed which ... Alison, researched the injury and found that VetStem Regenerative Cell Therapy may ...
(Date:4/4/2019)... ... 2019 , ... Biomeme, Inc. , a leading manufacturer ... solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ™. ... an English chemist and X-ray crystallographer who made significant contributions to the understanding ...
(Date:3/27/2019)... N.Y. (PRWEB) , ... March 27, 2019 , ... Lachman ... #60 at the Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site ... and Pharma 4.0, two key tracks on the agenda this year. , Executives from ...
Breaking Biology Technology:
Cached News: